These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17725806)

  • 1. Lack and restoration of sensitivity of lung cancer cells to cellular attack with special reference to expression of human leukocyte antigen class I and/or major histocompatibility complex class I chain related molecules A/B.
    Baba T; Hanagiri T; Ichiki Y; Kuroda K; Shigematsu Y; Mizukami M; Sugaya M; Takenoyama M; Sugio K; Yasumoto K
    Cancer Sci; 2007 Nov; 98(11):1795-802. PubMed ID: 17725806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a lung cancer antigen evading CTL attack due to loss of human leukocyte antigen (HLA) class I expression.
    Baba T; Hanagiri T; Takenoyama M; Shiota H; Kuroda K; Shigematsu Y; Ichiki Y; Uramoto H; So T; Yasumoto K
    Cancer Sci; 2010 Oct; 101(10):2115-20. PubMed ID: 20649604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of correlation between levels of MHC class I antigen and susceptibility to lysis of small cellular lung carcinoma (SCLC) by natural killer cells.
    Stam NJ; Kast WM; Voordouw AC; Pastoors LB; van der Hoeven FA; Melief CJ; Ploegh HL
    J Immunol; 1989 Jun; 142(11):4113-7. PubMed ID: 2541206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haplotype loss of HLA class I antigen as an escape mechanism from immune attack in lung cancer.
    So T; Takenoyama M; Mizukami M; Ichiki Y; Sugaya M; Hanagiri T; Sugio K; Yasumoto K
    Cancer Res; 2005 Jul; 65(13):5945-52. PubMed ID: 15994973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. General role of HLA class I molecules in the protection of target cells from lysis by natural killer cells: evidence that the free heavy chains of class I molecules are not sufficient to mediate the protective effect.
    Ciccone E; Pende D; Nanni L; Di Donato C; Viale O; Beretta A; Vitale M; Sivori S; Moretta A; Moretta L
    Int Immunol; 1995 Mar; 7(3):393-400. PubMed ID: 7794819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.
    Romagnani C; Pietra G; Falco M; Mazzarino P; Moretta L; Mingari MC
    Hum Immunol; 2004 May; 65(5):437-45. PubMed ID: 15172443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction and functional characterization of beta2-microglobulin (beta2-mu)-free HLA class I heavy chains expressed by beta2-mu-deficient human FO-1 melanoma cells.
    Wang Z; Arienti F; Parmiani G; Ferrone S
    Eur J Immunol; 1998 Sep; 28(9):2817-26. PubMed ID: 9754569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective human leukocyte antigen class I-associated antigen presentation caused by a novel beta2-microglobulin loss-of-function in melanoma cells.
    Chang CC; Ogino T; Mullins DW; Oliver JL; Yamshchikov GV; Bandoh N; Slingluff CL; Ferrone S
    J Biol Chem; 2006 Jul; 281(27):18763-73. PubMed ID: 16648140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells.
    Wang D; Quan Y; Yan Q; Morales JE; Wetsel RA
    Stem Cells Transl Med; 2015 Oct; 4(10):1234-45. PubMed ID: 26285657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-E/human beta2-microglobulin transgenic pigs: protection against xenogeneic human anti-pig natural killer cell cytotoxicity.
    Weiss EH; Lilienfeld BG; Müller S; Müller E; Herbach N; Kessler B; Wanke R; Schwinzer R; Seebach JD; Wolf E; Brem G
    Transplantation; 2009 Jan; 87(1):35-43. PubMed ID: 19136889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta-mediated recognition.
    Pietra G; Romagnani C; Falco M; Vitale M; Castriconi R; Pende D; Millo E; Anfossi S; Biassoni R; Moretta L; Mingari MC
    Eur J Immunol; 2001 Dec; 31(12):3687-93. PubMed ID: 11745389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for cytotoxic T lymphocyte response against human lung cancer: reconstitution of antigenic epitope with peptide eluted from lung adenocarcinoma MHC class I.
    Calhoun RF; Naziruddin B; Enriquez-Rincon F; Duffy BF; Ritter JM; Sundaresan S; Patterson GA; Cooper JD; Mohanakumar T
    Surgery; 2000 Jul; 128(1):76-85. PubMed ID: 10876189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NK cell killer Ig-like receptor repertoire acquisition and maturation are strongly modulated by HLA class I molecules.
    Sleiman M; Brons NH; Kaoma T; Dogu F; Villa-Forte A; Lenoble P; Hentges F; Kotsch K; Gadola SD; Vilches C; Zimmer J
    J Immunol; 2014 Mar; 192(6):2602-10. PubMed ID: 24554773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human T cell receptor-mediated recognition of HLA-E.
    García P; Llano M; de Heredia AB; Willberg CB; Caparrós E; Aparicio P; Braud VM; López-Botet M
    Eur J Immunol; 2002 Apr; 32(4):936-44. PubMed ID: 11920559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of HLA class Ia transcripts in human leukaemias.
    Majumder D; Bandyopadhyay D; Chandra S; Mukhopadhayay A; Mukherjee N; Bandyopadhyay SK; Banerjee S
    Immunogenetics; 2005 Sep; 57(8):579-89. PubMed ID: 16133450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformation dependence of MHC class I in the modulation of target cell sensitivity to natural killing.
    Hauser TA; Malyguine AM; Dawson JR
    Hum Immunol; 1998 Feb; 59(2):71-6. PubMed ID: 9536429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?
    Rouas-Freiss N; Marchal RE; Kirszenbaum M; Dausset J; Carosella ED
    Proc Natl Acad Sci U S A; 1997 May; 94(10):5249-54. PubMed ID: 9144223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of surface HLA-A,B,C molecules in tumour immunity.
    Möller P; Hämmerling GJ
    Cancer Surv; 1992; 13():101-27. PubMed ID: 1423320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability and Expression Levels of HLA-C on the Cell Membrane Modulate HIV-1 Infectivity.
    Parolini F; Biswas P; Serena M; Sironi F; Muraro V; Guizzardi E; Cazzoletti L; Scupoli MT; Gibellini D; Ugolotti E; Biassoni R; Beretta A; Malnati M; Romanelli MG; Zipeto D
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29070683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NK cells from human MHC class I (HLA-B) transgenic mice do not mediate hybrid resistance killing against parental nontransgenic cells.
    Kung SK; Su RC; Graham JJ; Chamberlain JW; Miller RG
    J Immunol; 1998 Jan; 160(2):674-80. PubMed ID: 9551902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.